Investment Thesis
ASP Isotopes demonstrates strong revenue growth (+475.5% YoY) with healthy 39.9% gross margins, but faces severe profitability challenges with operating losses of -$24.9M and negative free cash flow of -$23.9M. Despite a strong balance sheet with $207.3M cash and conservative 0.20x leverage, the company's inability to convert gross profit to operating profit and ongoing operational cash burn present substantial execution risk.
Strengths
- Exceptional revenue growth of 475.5% YoY demonstrating strong market demand
- Healthy gross margin of 39.9% indicating viable unit economics at product level
- Strong liquidity position with 4.39x current ratio and $207.3M cash providing operational runway
- Conservative capital structure with 0.20x debt/equity ratio and substantial equity cushion
Risks
- Significant operating losses of -$24.9M with -595.4% operating margin indicating inability to scale profitably
- Negative free cash flow of -$23.9M annually with ongoing operational cash burn unsustainable long-term
- Large gap between gross profit ($1.7M) and operating income (-$24.9M) suggests excessive operating expenses relative to revenue scale
- At current burn rate, $207.3M cash provides only ~8.7 years of runway, requiring path to profitability before depletion
Key Metrics to Watch
- Operating cash flow trajectory and timeline to cash flow breakeven
- Operating expense ratio as percentage of revenue and ability to achieve operating leverage
- Net loss reduction and timeline to net profitability
- Cash burn rate trends and estimated runway remaining
Financial Metrics
Revenue
4.2M
Net Income
-7.1M
EPS (Diluted)
$-0.06
Free Cash Flow
-23.9M
Total Assets
587.7M
Cash
207.3M
Profitability Ratios
Gross Margin
39.9%
Operating Margin
-595.4%
Net Margin
-170.4%
ROE
-2.5%
ROA
-1.2%
FCF Margin
-571.7%
Balance Sheet & Liquidity
Current Ratio
4.39x
Quick Ratio
4.37x
Debt/Equity
0.20x
Debt/Assets
49.1%
Interest Coverage
-2,653.87x
Long-term Debt
58.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-21T07:36:38.097240 |
Data as of: 2026-03-31 |
Powered by Claude AI